# Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery

> **NCT04230980** · PHASE3 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 74 (actual)

## Conditions studied

- Non-obstructive Azoospermia

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04230980
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-28
- **Primary completion:** 2022-11-28
- **Final completion:** 2022-12-16
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04230980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04230980, "Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04230980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*